Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News UK leading the way in cell and gene therapy trials

UK leading the way in cell and gene therapy trials

10th January 2019

The UK government Industrial Strategy Challenge Fund has provided more than £70 million funding to bolster the UK’s advanced therapy ecosystem. It was spent on a network of Advanced Therapies Treatment Centres and a new CGT Catapult cell and gene therapy manufacturing centre in Stevenage. This has facilitated an increase in the number of cell and gene clinical trials in the UK from 47% to 73%. There are 85 clinical trials and 875 preclinical research projects in cell and gene therapies ongoing in the UK at the moment, which is a 37% and 20% increase respectively in the last 12 months.
CEO of Cell and Gene Therapy Catapult, Keith Thompson, said: “The UK is fast becoming the premier hub for advanced therapy research and development. We are building the world’s most complete advanced therapies ecosystem. As the number of clinical trials has accelerated, the UK has made a determined effort to scale-up its research and manufacturing infrastructure to ensure this rich pipeline can continue to advance and grow.”

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.